methyl (3Z)-2-oxo-3-[(3E)-3-(2-piperazine-1,4-diium-1-ylethoxyimino)indolin-2-ylidene]indoline-5-carboxylate dichloride

ID: ALA5200264

Chembl Id: CHEMBL5200264

PubChem CID: 142579239

Max Phase: Preclinical

Molecular Formula: C24H27Cl2N5O4

Molecular Weight: 447.50

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\OCCN1CCNCC1)C(=O)N2.Cl.Cl

Standard InChI:  InChI=1S/C24H25N5O4.2ClH/c1-32-24(31)15-6-7-19-17(14-15)20(23(30)27-19)22-21(16-4-2-3-5-18(16)26-22)28-33-13-12-29-10-8-25-9-11-29;;/h2-7,14,25-26H,8-13H2,1H3,(H,27,30);2*1H/b22-20-,28-21+;;

Standard InChI Key:  YXTMUEVXTIJYQT-IFCOVLIBSA-N

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.50Molecular Weight (Monoisotopic): 447.1907AlogP: 1.89#Rotatable Bonds: 5
Polar Surface Area: 104.29Molecular Species: BASEHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.42CX Basic pKa: 9.19CX LogP: 1.45CX LogD: -0.15
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.28Np Likeness Score: -0.42

References

1. Wang H, Wang Z, Wei C, Wang J, Xu Y, Bai G, Yao Q, Zhang L, Chen Y..  (2021)  Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship.,  223  [PMID:34161865] [10.1016/j.ejmech.2021.113652]

Source